VlsE C6 peptide and IgG ELISA antibody analysis for clinical diagnosis of Lyme borreliosis in an endemic area [1]

Clinical Microbiology and Infection

Volumn 12, Issue 5, 2006, Pages 496-497

  Nyman, Dag ^a   Willen L ^a   Jansson, C ^a   Carlsson, S A ^a   Granlund, H ^a   Wahlberg, P ^a  

^a Aland Central Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C6; IMMUNOGLOBULIN G; RECOMBINANT ANTIGEN; RECOMBLOT;

ANTIBODY DETECTION; CALCULATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; LETTER; LYME DISEASE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY AND SPECIFICITY; SEROLOGY;

EID: 33645646049     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01374.x     Document Type: Letter

References (2)

1. Jansson C, Carlsson S-A, Granlund H, Wahlberg P, Nyman D. Analysis of Borrelia burgdorferi IgG antibodies with a combination of IgG ELISA and VlsE C6 peptide ELISA. Clin Microbiol Infect 2005;11:147-150.
2. Carlsson S-A, Granlund H, Nyman D, Wahlberg P. IgG seroprevalence of Lyme borreliosis in the population of the Åland Islands in Finland. Scand J Infect Dis 1998;30:501-503.